Galderma Acquires ZO Skin Health for $1.5 Billion
Swiss dermatology company Galderma Group AG (GALDY) announced the acquisition of U.S.-based skincare firm ZO Skin Health Inc. in an all-cash deal valued at $1.5 billion. The transaction is intended to bolster Galderma’s position in the physician-dispensed skincare market, particularly within the United States. ZO Skin Health was previously owned by Blackstone and the Obagi family before being sold off as part of this acquisition. This move aligns with Galderma's strategy to expand its portfolio through strategic acquisitions that enhance product offerings for dermatologists and their patients.
Topics: acquisition dermatology skincare market